Latest profit margin for Natera: -9.05% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Natera (NTRA) currently reports a profit margin of -9.05% as of March 2026. That compares with -10.36% in the prior-year period — up 12.7% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Natera's profit margin history and peer comparisons.
Natera's profit margin increased from -10.36% to -9.05% — a 12.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Natera's profit margin of -9.05% is lower than the Healthcare sector average of 15.29%. That is roughly 159.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Natera's current -9.05% should be judged against Healthcare norms (sector average: 15.29%) and against NTRA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -9.05%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Natera, and consider following NTRA for alerts when major investors trade the stock.